EMERGENT BIOSOLUTIONS INC (EBS) Stock Analyst Earnings Estimates
NYSE:EBS - New York Stock Exchange, Inc. - US29089Q1058 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.774B 14.03% | 1.118B -36.99% | 1.049B -6.10% | 1.115B 6.26% | 1.142B 2.42% | 998.89M -12.53% | 761.34M -23.78% | 1.456B 91.24% | 1.603B 10.10% | 1.305B -18.59% | 1.024B -21.53% | 977.68M -4.52% | |
| EBITDA YoY % growth | 506.9M -14.75% | -20M -103.95% | -76.4M -282.00% | 186.65M 344.31% | 58.176M -68.83% | 134.43M 131.07% | 133.62M -0.60% | 132.31M -0.98% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 383.1M -20.20% | -163.3M -142.63% | -201.5M -23.39% | -75.902M 62.33% | 137.42M 281.05% | 70.7M -48.55% | 12.625M -82.14% | 510.05M 3,940.00% | 560.55M 9.90% | 456.52M -18.56% | 358.55M -21.46% | 342.39M -4.51% | |
| Operating Margin | 21.60% | -14.61% | -19.20% | -6.81% | 12.03% | 7.08% | 1.66% | 35.03% | 34.97% | 34.98% | 35.01% | 35.02% | |
| EPS YoY % growth | 6.00 -23.57% | -2.26 -137.67% | -5.48 -142.48% | -0.82 84.98% | 2.09 353.99% | 1.54 -26.57% | -0.04 -102.63% | -0.04 | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 35.07% | 1.15 95.15% | -0.10 95.65% | 1.14 -16.69% | -0.13 73.74% |
| Revenue Q2Q % growth | 257.21M -7.01% | 281.79M -6.20% | 312.09M 22.53% | 307.04M 4.51% | 276.74M 7.59% |
| EBITDA Q2Q % growth | 22.927M -71.80% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 15.722M 135.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.37 385.42% | 0.14 | 1.23 | 868.88% |
| Q2 2024 Q2Q % growth | -2.32 -118.87% | -0.95 | -1.37 | -143.07% |
| Q1 2024 Q2Q % growth | 0.59 118.61% | -0.87 | 1.46 | 167.93% |
| Q4 2023 Q2Q % growth | -0.77 -148.39% | -0.19 | -0.58 | -301.25% |
| Q3 2023 Q2Q % growth | -0.48 62.20% | -0.23 | -0.25 | -112.80% |
| Q2 2023 Q2Q % growth | -1.06 -23.26% | -0.49 | -0.57 | -115.65% |
| Q1 2023 Q2Q % growth | -3.17 -1,861.11% | -1.25 | -1.92 | -153.11% |
| Q4 2022 Q2Q % growth | -0.31 -106.89% | 0.04 | -0.35 | -797.57% |
| Q3 2022 Q2Q % growth | -1.27 -252.78% | -0.06 | -1.21 | -1,938.96% |
| Q2 2022 Q2Q % growth | -0.86 -360.61% | 0.38 | -1.24 | -327.06% |
| Q1 2022 Q2Q % growth | 0.18 -88.24% | 0.13 | 0.05 | 42.57% |
| Q4 2021 Q2Q % growth | 4.50 22.62% | 4.31 | 0.19 | 4.38% |
| Q3 2021 Q2Q % growth | -0.36 -116.44% | 2.37 | -2.73 | -115.18% |
| Q2 2021 Q2Q % growth | 0.33 -83.33% | 1.56 | -1.23 | -78.83% |
| Q1 2021 Q2Q % growth | 1.53 15,200.00% | 1.13 | 0.40 | 34.91% |
| Q4 2020 Q2Q % growth | 3.67 133.76% | 3.22 | 0.45 | 14.01% |
| Q3 2020 Q2Q % growth | 2.19 80.99% | 2.14 | 0.05 | 2.35% |
| Q2 2020 Q2Q % growth | 1.98 1,550.00% | 0.69 | 1.29 | 186.89% |
| Q1 2020 Q2Q % growth | 0.01 107.69% | 0.01 | 0.00 | -0.99% |
| Q4 2019 Q2Q % growth | 1.57 | 1.75 | -0.18 | -10.37% |
| Q3 2019 Q2Q % growth | 1.21 | 0.91 | 0.30 | 33.69% |
| Q2 2019 Q2Q % growth | 0.12 | 0.17 | -0.05 | -28.91% |
| Q1 2019 Q2Q % growth | -0.13 | 0.10 | -0.23 | -236.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 293.8M 8.61% | 300.48M | -6.68M | -2.22% |
| Q2 2024 Q2Q % growth | 254.7M -24.62% | 191.9M | 62.8M | 32.73% |
| Q1 2024 Q2Q % growth | 300.4M 81.95% | 222.45M | 77.95M | 35.04% |
| Q4 2023 Q2Q % growth | 276.6M -16.36% | 296.47M | -19.87M | -6.70% |
| Q3 2023 Q2Q % growth | 270.5M 12.71% | 239.81M | 30.69M | 12.80% |
| Q2 2023 Q2Q % growth | 337.9M 39.23% | 218.33M | 119.57M | 54.77% |
| Q1 2023 Q2Q % growth | 165.1M -46.31% | 144.71M | 20.39M | 14.09% |
| Q4 2022 Q2Q % growth | 330.7M -54.27% | 299.59M | 31.11M | 10.38% |
| Q3 2022 Q2Q % growth | 240M -27.05% | 270.98M | -30.98M | -11.43% |
| Q2 2022 Q2Q % growth | 242.7M -38.94% | 273.65M | -30.95M | -11.31% |
| Q1 2022 Q2Q % growth | 307.5M -10.35% | 286.41M | 21.09M | 7.36% |
| Q4 2021 Q2Q % growth | 723.2M 24.05% | 698.27M | 24.93M | 3.57% |
| Q3 2021 Q2Q % growth | 329M -14.59% | 491.71M | -162.71M | -33.09% |
| Q2 2021 Q2Q % growth | 397.5M 0.71% | 402.92M | -5.42M | -1.35% |
| Q1 2021 Q2Q % growth | 343M 78.18% | 362.06M | -19.06M | -5.26% |
| Q4 2020 Q2Q % growth | 583M 61.81% | 569.58M | 13.42M | 2.36% |
| Q3 2020 Q2Q % growth | 385.2M 23.54% | 442.31M | -57.11M | -12.91% |
| Q2 2020 Q2Q % growth | 394.7M 62.29% | 297.68M | 97.02M | 32.59% |
| Q1 2020 Q2Q % growth | 192.5M 1.00% | 200.89M | -8.39M | -4.18% |
| Q4 2019 Q2Q % growth | 360.3M | 360.99M | -690K | -0.19% |
| Q3 2019 Q2Q % growth | 311.8M | 292.16M | 19.64M | 6.72% |
| Q2 2019 Q2Q % growth | 243.2M | 214.18M | 29.02M | 13.55% |
| Q1 2019 Q2Q % growth | 190.6M | 203.18M | -12.58M | -6.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 22.66% | -102.04% | 18.5% | 51.2% |
| Revenue | -1.67% | -6.42% | -0.36% | -1.68% |